Glenmark Pharma | Business Upturn

Latest Articles

Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more

Stock Market · Dec 17, 2025

blank

Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib

Corporates · Dec 16, 2025

blank

Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market

Corporates · Dec 11, 2025

blank

Glenmark Pharma receives US FDA EIR with VAI status for Monroe facility

Corporates · Nov 27, 2025

blank

Glenmark Pharma launches world’s first bebulized triple therapy for COPD in India

Stock Market · Nov 25, 2025

blank

Top Q2 results today, November 14: Tata Motors PV, Oil India, Glenmark Pharma, MRF and more to announce earnings

Quarterly Results · Nov 14, 2025

blank

Glenmark Pharma board declares Rs 2.50 interim dividend for FY26

Stock Market · Sep 26, 2025

blank

Top stocks to watch today, September 25: Tata Motors, NTPC, Glenmark Pharma, Newgen Software, Lupin and more

Stock Market · Sep 25, 2025

blank

Glenmark Pharma secures $1.1B deal with Hengrui for exclusive global rights to HER2-targeted therapy Trastuzumab Rezetecan

Corporates · Sep 24, 2025

blank

Glenmark Pharma shares jump over 2% after its subsidiary gets $700 million from AbbVie for licensing deal

Stock Market · Sep 9, 2025

blank

Glenmark Pharma receives $700 million upfront payment from AbbVie for global licensing deal

Corporates · Sep 9, 2025

blank

Glenmark Pharma initiates multi-country Phase 3 Clinical Trial for Envafolimab in Stage III NSCLC

Corporates · Sep 5, 2025

blank

Glenmark Pharma shares jump over 2% as HSBC maintains ‘Buy’ rating with target price of Rs 2,380

Stock Market · Sep 3, 2025

blank

[Brokerages] Stocks to watch today, September 3: ITC, Adani Power, Indus Towers, UBL, Glenmark Pharma and more

Stock Market · Sep 3, 2025

blank

Glenmark Pharma to launch Eribulin Mesylate Injection in the US market

Corporates · Sep 2, 2025

Showing 15 of 31 articles